2009 Leadership Retreat - Vaccine/Immuno-based Therapy Meeting Presentations

Monday, December 7, 2009     v     2:15 P.M. – 5:00 P.M.

RV 144, “The HIV Vaccine Efficacy Trial in Thailand”

-     Merlin Robb, M.D.

-     Sanofi-Aventis Pateur Representative

HPTN 027, “ALVAC-HIV vCP1521 in Ugandan Infants”

-     Laura Guay, M.D.

NWCS 088, “Characteristics (Immunologic, Virologic and Host-Genetic) of Perinatally HIV-Infected Children who are Long Term Non Progressors: A Substudy of P219/219C”

-     Stephen Spector, M.D.

Study Reviews:

-     South African Capsule – Elizabeth McFarland, M.D.

-     Cord Blood Capsule – Coleen Cunningham, M.D.

Study Updates:

-     P1049, “A Phase I/II Study of the Safety, Tolerability and Immuniogencity of a Topical Therapeutic DNA Dendritic Cell Vaccine (DERMAVIR) Patch in Children, Adolescents, and Young Adults with HIV”– Elizabeth McFarland, M.D.

-     P1082, “A Phase I/II Study of the Safety and Immunogencity of DNA/MVA Immunizations in HIV-1 Infected Young Adults with Suppressed Viremia on HAART” – Coleen Cunningham, M.D